DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Porfiromycin is an investigational drug.
There have been 4 clinical trials for Porfiromycin. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 1992.
The most common disease conditions in clinical trials are Head and Neck Neoplasms, Neoplasms, Unknown Primary, and Carcinoma. The leading clinical trial sponsors are Boehringer Ingelheim, Yale University, and [disabled in preview].
Recent Clinical Trials for Porfiromycin
|Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients||Boehringer Ingelheim||Phase 3|
|Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors||Boehringer Ingelheim||Phase 1|
|Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer||Boehringer Ingelheim||Phase 3|